We are grateful to Johnson & Johnson Innovation for funding this vital work and are honored to advance medicine for our veterans and military community. This grant will provide Immunophotonics with the opportunity to expand the use of IP-001 into a previously untested combination with chemotherapy as a means of inducing systemic anti-tumor immune responses,...
Immunophotonics, Inc is proud to have been selected by YoungStartup Ventures to present at the Florida Venture Summit in Miami on December 6th & 7th. Lu Alleruzzo, CEO of Immunophotonics’ will be attending and presenting.
Congratulations to Professor Wei Chen and his lab at the University of Oklahoma for their publication in one of the top ranked oncology and immunology peer-reviewed journals, the Journal for ImmunoTherapy of Cancer (JITC), on their paper, “Localized ablative immunotherapy drives de novo CD8+ T-cell responses to poorly immunogenic tumors”. Check out this key publication on how ablation...
Immunophotonics, Inc. would like to congratulate Wei Chen, Ph.D. on his recently awarded Grant by the National Cancer Institute of Health’s (NIH) National Cancer Institute for pancreatic cancer research. Check out the Official Press Release
Dr. Theresa Visarius, Immunophotonics Vice President of Business Development and Managing Director of Immunophotonics Switzerland will be attending Bio-Europe 2022 October 24th to 26th.
Lu Alleruzzo, Co-Founder & CEO, at Immunophotonics, Inc., will be attending the BioPharm America 2022 conference in Boston on September 28 & 29th.
Lu Alleruzzo, Co-Founder & CEO, at Immunophotonics, Inc. will be attending the RESI Boston 2022 Partnering Platform, September 21st & 22nd in Boston at the Westin Copley Place.
Dr. Theresa Visarius, Immunophotonics Vice President Business Development and Managing Director of the Swiss subsidiary IPS Biopharma AG will be at the SACHS Associates 22nd Annual Biotech in Europe Forum for Global Partnering and Investment on Wednesday and Thursday, September 21st & 22nd.
Tomas Hode, PhD, Co-Founder, CIO, and President at Immunophotonics, Inc. attended the Cardiovascular and Interventional Radiology Society of Europe (CIRSE) Conference on September 10 – 14, 2022 in Barcelona, Spain.
Lu Alleruzzo, Co-Founder & CEO at Immunophotonics, Inc. attended the European Society of Medical Oncology (ESMO) Congress in Paris, France on September 9 – 13, 2022.
